Blood Cancers | Tumor

Breaking Down the Stigma and How to Better Understand Rare Blood Cancers

May 1st 2025, 8:00pm

Video

Dr. Neha Mehta-Shah discusses ways patients with rare blood cancers, such as lymphoma, can better understand their specific subtype of disease.

Understanding the Use of Bispecific Antibodies in Multiple Myeloma

April 4th 2025, 9:00pm

Article

Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.

The Positivity Trap of Follicular Lymphoma and Cancer

March 31st 2025, 5:00pm

Article

As a lymphoma survivor, I struggle with the positivity trap — sometimes, I just want my fears validated instead of being reassured everything is fine.

Itolizumab Shows Long-Term Treatment Benefits in Acute GVHD

March 27th 2025, 3:00pm

Article

Although itolizumab did not improve response rates at Day 29 for patients with acute GVHD, the therapy showed significant benefits in long-term outcomes.

First Patients Dosed in WU-CART-007 Trial for Blood Cancer Subtypes

March 22nd 2025, 6:00pm

Article

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or T cell lymphoblastic lymphoma.

FDA Grants Fast Track Designation for Azer-Cel in Lymphoma Subset

March 21st 2025, 4:00pm

Article

FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large B-cell lymphoma.

Darzalex Plus Revlimid Improves Outcomes in Newly Diagnosed Myeloma

March 18th 2025, 9:00pm

Article

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell transplantation in multiple myeloma.

Orca-T Doubles Graft-Versus-Host Disease-Free Survival in Leukemia

March 18th 2025, 4:00pm

Article

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease across leukemia subtypes.

A Picture is Worth Ten Thousand Words When it Comes to Cancer

March 17th 2025, 5:00pm

Article

Years after losing my brother to Hodgkin’s lymphoma, I learned something about how he felt facing a terminal diagnosis by studying an old Polaroid.

Bringing Together the CAR T-Cell Therapy Community

March 12th 2025, 7:26pm

Article

It’s easy to think of scientific researchers as existing in a vacuum.